{
    "clinical_study": {
        "@rank": "89193", 
        "acronym": "ECP-015", 
        "arm_group": {
            "arm_group_label": "XLHED", 
            "description": "Those with the condition of XLHED"
        }, 
        "brief_summary": {
            "textblock": "The proposed natural history study will enroll male and female patients, ages 36 months and\n      younger, who have a diagnosis of XLHED based on genetic testing and who have not received an\n      investigational study drug. The study protocol will include collection of all relevant\n      medical history and documentation of clinical outcomes using age-appropriate, minimally\n      invasive technologies.  Data will be collected both retrospectively, back to pregnancy\n      assessments that may be available, and prospectively through age 5 yrs."
        }, 
        "brief_title": "Natural History and Outcomes in X-Linked Hypohidrotic Ectodermal Dysplasia", 
        "completion_date": {
            "#text": "October 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "X-Linked Hypohidrotic Ectodermal Dysplasia", 
        "condition_browse": {
            "mesh_term": [
                "Ectodermal Dysplasia", 
                "Ectodermal Dysplasia 1, Anhidrotic"
            ]
        }, 
        "detailed_description": {
            "textblock": "Important to the development and regulatory approval of therapies for XLHED will be the\n      collection of data on the clinical history and prospective health of those affected by\n      XLHED. The proposed natural history study will enroll male and female patients, ages 36\n      months and younger, who have a diagnosis of XLHED based on genetic testing and who have not\n      received an investigational study drug. The study protocol will include collection of all\n      relevant medical history and documentation of clinical outcomes using age-appropriate,\n      minimally invasive technologies.  Data will be collected both retrospectively, back to\n      pregnancy assessments that may be available, and prospectively through age 5 yrs.\n      Genotype-phenotype correlations in XLHED, based on well-documented health records and\n      prospective assessments on genetically-confirmed individuals, may now provide new and\n      clinically-predictive information for the benefit of patients, families, health care\n      providers and clinical investigators designing trials for therapeutic interventions."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Subjects must meet all of the following criteria to be enrolled in this study:\n\n          1. Confirmed genetic diagnosis of XLHED\n\n          2. Written informed consent of both parents (if reasonably available)\n\n        Exclusion Criteria:\n\n        Subjects who meet any of the following criteria cannot be enrolled in this study:\n\n          1. Medically-significant complications or congenital anomalies outside of those\n             considered to be associated with the diagnosis or status of XLHED\n\n          2. Having received an investigational study drug prior to enrollment. For subjects less\n             than 6 months of age, the mother cannot have taken an investigational drug during her\n             pregnancy.\n\n          3. Known hypersensitivity to pilocarpine or pilocarpine-like muscarinic agonists\n\n          4. Presence of pacemakers"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "36 Months", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Those with the condition of XLHED up to age 36 months"
            }
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 26, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02099552", 
            "org_study_id": "ECP-015"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "X-Linked hypohidrotic ectodermal dysplasia", 
            "XLHED", 
            "Hypohidrotic ectodermal dysplasia", 
            "HED", 
            "Christ-Siemens-Touraine syndrome"
        ], 
        "lastchanged_date": "April 25, 2014", 
        "link": [
            {
                "description": "Sponsor website", 
                "url": "http://www.edimerpharma.com"
            }, 
            {
                "description": "XLHED Network sign-up", 
                "url": "http://www.xlhednetwork.com"
            }, 
            {
                "description": "Tools for those seeing genetic counseling", 
                "url": "http://www.havetheconvo.com"
            }
        ], 
        "location": [
            {
                "contact": {
                    "email": "ophir.klein@ucsf.edu", 
                    "last_name": "Ophir Klein, MD PhD", 
                    "phone": "415-476-9513"
                }, 
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94143"
                    }, 
                    "name": "University of California, San Francisco"
                }, 
                "investigator": {
                    "last_name": "Ophir Klein, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "LKehoe@childrensnational.org", 
                    "last_name": "Lindsay Kehoe", 
                    "phone": "202-476-4549"
                }, 
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20010"
                    }, 
                    "name": "Children's National Medical Center"
                }, 
                "investigator": {
                    "last_name": "Pranoot Tanpaiboon, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "grange_d@kids.wustl.edu", 
                    "last_name": "Dorothy Grange, MD", 
                    "phone": "314-454-6093"
                }, 
                "contact_backup": {
                    "last_name": ", MD"
                }, 
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63110"
                    }, 
                    "name": "Washington University School of Medicine"
                }, 
                "investigator": {
                    "last_name": "Dorothy K Grange, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "holm.schneider@uk-erlangen.de", 
                    "last_name": "Holm Schneider, MD, PhD", 
                    "phone": "+49 9131 8533775"
                }, 
                "facility": {
                    "address": {
                        "city": "Erlangen", 
                        "country": "Germany", 
                        "state": "Bavaria", 
                        "zip": "91054"
                    }, 
                    "name": "University Hospital Erlangen"
                }, 
                "investigator": {
                    "last_name": "Holm Schneider, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "clarkeaj@cf.ac.uk", 
                    "last_name": "Angus Clarke, MD", 
                    "phone": "44 29 2074 4051"
                }, 
                "facility": {
                    "address": {
                        "city": "Cardiff", 
                        "country": "United Kingdom", 
                        "zip": "CF14 4XW"
                    }, 
                    "name": "University Hospital of Wales"
                }, 
                "investigator": {
                    "last_name": "Angus Clarke, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Germany", 
                "United Kingdom"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "Natural History and Outcomes in X-Linked Hypohidrotic Ectodermal Dysplasia", 
        "overall_contact": {
            "email": "ramsey@edimerpharma.com", 
            "last_name": "Ramsey Johnson, MSM", 
            "phone": "617-758-4305"
        }, 
        "overall_official": {
            "affiliation": "Edimer Pharmaceuticals", 
            "last_name": "Kenneth Huttner, MD, PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2019", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "To characterize the clinical course of untreated XLHED male and female subjects in early childhood, capturing data from physician and hospital records, medical history including growth and development, and family interviews.", 
                "measure": "To assess clinical course of untreated XLHED individuals", 
                "safety_issue": "No", 
                "time_frame": "Up to 5 years of life"
            }, 
            {
                "description": "To characterize the phenotype of untreated XLHED male subjects and female in early childhood with endpoint assessments including sweat (males only), dentition, craniofacial development, pulmonary and ocular health.", 
                "measure": "To assess the phenotype of untreated XLHED individuals", 
                "safety_issue": "No", 
                "time_frame": "Up to 5 years of life"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02099552"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "To assess changes in endpoint assessments over time (growth and development)", 
                "safety_issue": "No", 
                "time_frame": "Baseline and yearly up through 5 years of age"
            }, 
            {
                "measure": "To assess changes in endpoint assessments over time (Mortality/Hospitalizations/Infections/Fevers/Heat Intolerance)", 
                "safety_issue": "No", 
                "time_frame": "Baseline and yearly up through 5 years of age"
            }, 
            {
                "measure": "To assess changes in endpoint assessments over time (sweat rate)", 
                "safety_issue": "No", 
                "time_frame": "Baseline and yearly through 5 years of age"
            }, 
            {
                "measure": "To assess changes in endpoint assessments over time (Dentition)", 
                "safety_issue": "No", 
                "time_frame": "Baseline and yearly through 5 years of age"
            }, 
            {
                "measure": "To assess changes in endpoint assessments over time (dry eye)", 
                "safety_issue": "No", 
                "time_frame": "Baseline and yearly through 5 years of age"
            }, 
            {
                "measure": "To assess changes in endpoint assessments over time (skin, hair and nail health)", 
                "safety_issue": "No", 
                "time_frame": "Baseline through 5 years of age"
            }, 
            {
                "measure": "To assess changes in endpoint assessments over time (respiratory health)", 
                "safety_issue": "No", 
                "time_frame": "Baseline and yearly through 5 years of age"
            }, 
            {
                "measure": "To assess changes in endpoint assessments over time (craniofacial development)", 
                "safety_issue": "No", 
                "time_frame": "Baseline and yearly through 5 years of age"
            }, 
            {
                "description": "To correlate clinical course and endpoint outcomes with EDA genotype in untreated XLHED-affected male and female subjects.", 
                "measure": "To assess genotype-phenotype correlation in XLHED affected individuals", 
                "safety_issue": "No", 
                "time_frame": "Baseline through 5 years of age"
            }
        ], 
        "source": "Edimer Pharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Edimer Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Observational Model: Cohort", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}